United States · FDA National Drug Code directory
testosterone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45802-281_a7c10e20-f92f-4b14-a281-8118abfd4809
- Product NDC
- 45802-281
- Form
- GEL
- Composition / generic term
- testosterone
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190627
- Source listing expiry
- 20261231
Source-listed ingredients
- TESTOSTERONE — 20.25 mg/1.25g
These values do not establish equivalence or a dose recommendation.
Packages
- 30 PACKET in 1 CARTON (45802-281-39) / 1.25 g in 1 PACKET (45802-281-03) · 45802-281-39
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →